News
Co-authored with “Hidden Opportunities” Healthcare is a Critical Requirement Over 131 million people (66% of all adults) in the United States use prescription drugs....
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various...
News
First Bank (NASDAQ:FRBA) Q4 2024 Results Conference Call January 24, 2025 9:00 AM ET Company Participants Patrick Ryan – President and Chief Executive OfficerAndrew...
News
Origin Bancorp, Inc. (NYSE:OBK) Q4 2024 Results Conference Call January 23, 2025 9:00 AM ET Company Participants Chris Reigelman – Director, Investor RelationsDrake Mills...
News
The 2024 Lexus LC luxury coupe or convertible keeps the grand touring flame burning bright with lots of features, plenty of poise, and an...
News
My Top 10 Personal Holdings Many readers have expressed interest in my personal investments, and I think it is important to be as transparent...
News
This article is reprinted by permission from NerdWallet. It’s the summer of Barbie. The movie release date is set for July 21, but the...
News
When it comes to investment returns, real estate has historically been a great option. Many people have achieved great wealth by investing in real...
News
Where are you headed this summer? Everyone knows all the usual vacation hot spots, the popular go-to locales — wonderful places, sure, but too...
News
In this article, I will outline why I think T. Rowe Price Group, Inc. (NASDAQ:TROW) is a buy at this time. I will explain...
News
Introduction According to the 2022 10K, ExlService Holdings (NASDAQ:EXLS), is a leading data analytics and digital operations and solutions company that partners with clients...
News
Lucid Group (NASDAQ:LCID) is full of risks. In times of uncertain macroeconomic conditions and a high-interest rate environment, the company is immensely unprofitable. In...
News
Introduction Reneo Pharmaceuticals (NASDAQ:RPHM) is a clinical-stage company developing therapies for rare genetic mitochondrial diseases, characterized by impaired mitochondrial ATP production. The company’s primary...
